Dr. Patel on Benefit of Ipilimumab/Nivolumab Combo in High-Grade Neuroendocrine Carcinoma

1 Views
administrator
administrator
07/09/23

Sandip Patel, MD, discusses the benefit of the immune checkpoint inhibitor combination of ipilimumab (Yervoy) and nivolumab (Opdivo) in patients with rare, high-grade neuroendocrine tumors.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next